Neurotrope, Inc.
(NASDAQ : NTRP)

( )
NTRP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.11%446.061.0%$855.21m
DHRDanaher Corp. -2.02%221.210.7%$632.76m
MDTMedtronic Plc 0.78%111.020.6%$553.14m
ABTAbbott Laboratories -1.48%109.250.8%$546.30m
BSXBoston Scientific Corp. -1.13%33.321.0%$534.15m
DXCMDexCom, Inc. 1.65%321.097.8%$490.34m
ISRGIntuitive Surgical, Inc. -1.60%719.052.3%$407.40m
ALGNAlign Technology, Inc. 6.75%476.586.4%$357.54m
BDXBecton, Dickinson & Co. -1.47%228.461.0%$329.06m
SYKStryker Corp. 0.12%233.131.3%$291.92m
BAXBaxter International, Inc. -1.60%75.791.8%$277.97m
EWEdwards Lifesciences Corp. 0.17%84.680.4%$239.36m
IDXXIDEXX Laboratories, Inc. -0.97%459.793.8%$221.66m
ZBHZimmer Biomet Holdings, Inc. 0.16%146.181.7%$217.73m
QDELQuidel Corp. -5.92%176.117.7%$201.82m

Company Profile

Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY.